S&P 500
7,754.90
+0.25%
Dow Jones
53,844.60
+0.04%
Nasdaq 100
29,772.60
+0.70%
Russell 2000
3,049.42
+0.69%
FTSE 100
10,856.80
+0.21%
Nikkei 225
68,478.20
+1.93%

Investing

ALC logo Alcon : ALC

Price Target $90 ↑23.4%
›

ALC

Stock Data

$75.35

Change up

$1.72 (2.34%)

Asset Type

Common Stock

Exchange

NYSE

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

MEDICAL INSTRUMENTS & SUPPLIES

Alcon Inc. is a global leader in eye care, offering a wide range of products for professionals and patients. From surgical equipment and instruments to intraocular lenses and consumables, Alcon caters to various eye care needs. Its portfolio includes advanced systems for cataract surgery, vitreoretinal products, LASIK treatment lasers, and glaucoma management devices. Additionally, Alcon provides a variety of contact lenses and ocular health products, addressing issues like dry eye and allergies. Founded in 1945 and based in Geneva, Switzerland, Alcon is dedicated to enhancing vision and improving lives.

Latest Activity

ALCAlcon
Q2 2026
EPS
$0.84
est $0.76+11.2%
Revenue
$2.78B
est $2.77B+0.5%

Alcon raised full-year core EPS growth guidance to 12% to 15% in constant currency, exceeding expectations, even as a $402 million pre-tax impairment from the scrapped PowerVision lens programs took GAAP earnings to zero. Keep an eye on the stock into the earnings call at 8:00 AM ET Tuesday.

Quarterly EPS — reported vs estimate
Read more

All Alcon Articles

12 Articles